Literature DB >> 68274

Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.

J L Reid, L M Wing, H J Dargie, C A Hamilton, D S Davies, C T Dollery.   

Abstract

Treatment was interrupted abruptly in 6 hypertensive patients receiving clonidine 0-45-5-4 mg daily. Blood-pressure rose to pretreatment levels within 24-48 h of withdrawal and was accompanied by insomnia, headache, flushing, sweating, and apprehension. These symptoms began 18-20 h after the last dose of clonidine. Plasma-noradrenaline levels and urinary catecholamine excretion increased 24-72 h after withdrawal of clonidine. The subjective symptoms were most prominent in patients on higher doses (greater than 1 mg/day) and in those who had previously been receiving treatment with other antihypertensive drugs. One patient on a very low daily dose (0-15 mg) of clonidine had no symptoms and no significant changes in blood-pressure or catecholamine production after drug withdrawal.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 68274     DOI: 10.1016/s0140-6736(77)92715-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  33 in total

1.  Non-sustained ventricular tachycardia following clonidine withdrawal.

Authors:  P Jain; A Misra
Journal:  Postgrad Med J       Date:  1991-04       Impact factor: 2.401

Review 2.  Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection.

Authors:  P Bousquet; J Feldman
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 3.  The implications of noncompliance with antihypertensive medication.

Authors:  B Girvin; G D Johnston
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

4.  Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin.

Authors:  O Lederballe Pedersen; E Mikkelsen; J Lanng Nielsen; N J Christensen
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

5.  Hyperadrenergic state following acute withdrawal from clonidine used at supratherapeutic doses.

Authors:  N J Sarlis; O Caticha; J L Anderson; C Kablitz; F S Shihab
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

6.  Failure of labetalol to prevent hypertension due to clonidine withdrawal.

Authors:  D M Hurley; R Vandongen; L J Beilin
Journal:  Br Med J       Date:  1979-04-28

7.  Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine.

Authors:  H Rupp; B Maisch; C G Brilla
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

8.  Clonidine dependence in the guinea-pig isolated ileum.

Authors:  H O Collier; N J Cuthbert; D L Francis
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

Review 9.  Effects of antihypertensive drugs on endocrine function.

Authors:  E P Brass
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

10.  Clonidine withdrawal. Mechanism and frequency of rebound hypertension.

Authors:  G G Geyskes; P Boer; E J Dorhout Mees
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.